Richard Craig explores the new concept of "abusive denigration" in the context of competition law principles applicable to dominant companies and the implications it may carry.
A legal toolkit for life sciences companies and their investors providing access to information on:
Paul England analyses the potential risks posed by new 3D printing technology to rightsholders in the medical devices sector and solutions offered by the (yet to be adopted) Medical Devices Regulation...read more
Paul England discusses the Court of Appeal decision in AstraZeneca v KRKA upholding the largest award ever made by the Patents Court as a result of the discharge of a preliminary injunction...read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...